Get the Stockscreener App
1.95
9.68%
-0.22
After Hours:
2.20
0.25
+12.82%
Tc Biopharm Holdings Plc Adr Stock (TCBP) Forecast
The Tc Biopharm Holdings Plc Adr (TCBP) stock price forecast for the next 30 days is generally positive, with an average analyst price target of $749.02, representing a +38,311% increase from the current price of $1.95. The highest analyst price target is $746.52, and the lowest is $751.52.
Disclaimer: The information on this page is not intended to be financial advice. It is for general information only and should not be used to make any investment decisions. Please consult with a professional financial advisor before making any investment decisions.
12-Month TCBP Price Target
Average 540.09
(+27,597% Upside)
Is Tc Biopharm Holdings Plc Adr (TCBP) A Buy Now?
Oscillators
| Name | Value | Action |
|---|---|---|
| RSI(14) | 53.63 | Neutral |
| STOCH(9,6) | 16.80 | Buy |
| STOCHRSI(14) | 43.02 | Neutral |
| MACD(12,26) | 0.3953 | Sell |
| ADX(14) | 34.64 | Buy |
| William %R | -98.56 | Buy |
| CCI(14) | -36.91 | Neutral |
Buy: 3
Sell: 1
Neutral: 3
Summary: Neutral
Moving Averages
| Period | Simple | Exponential |
|---|---|---|
| MA10 |
2.349
Sell
|
2.1888
Sell
|
| MA20 |
1.9061
Buy
|
1.9191
Buy
|
| MA50 |
1.0173
Buy
|
1.4535
Buy
|
| MA100 |
1.3026
Buy
|
2.0865
Sell
|
| MA200 |
3.7181
Sell
|
6.6265
Sell
|
Buy: 5
Sell: 5
Neutral: 0
Summary: Neutral
According to our latest analysis, TCBP could be considered a Potential Buy, with 17 technical analysis indicators signaling 8 Buy signals, 6 signaling Sell signals and 3 Neutral signals. This might be a good time to open fresh positions on TCBP, as trading bullish markets is always a lot easier
- RSI (Relative Strength Index): The RSI(14) value of 53.63 indicates that TCBP is neither overbought nor oversold. It suggests a neutral sentiment in the short term.
- STOCH (Stochastic Oscillator): The STOCH value of 16.8 indicates that TCBP is oversold. This indicates that TCBP price is at or near the lowest level over a specified lookback period.
- STOCHRSI (Stochastic Relative Strength Index): The STOCHRSI value of 43.02 indicates that TCBP is neither overbought nor oversold. It indicates a balanced market sentiment without any extreme buying or selling pressure.
- ADX (Average Directional Index): The ADX value of The ADX value of 34.64 suggests a moderate trend in the market. It indicates that there is more conviction behind the directional movement compared to lower ADX values. You should consider this as a potential opportunity to enter trades in the direction of the trend.
- CCI (Commodity Channel Index): A CCI(14) value of A CCI(14) value of -36.91 indicates that TCBP is not in oversold or overbought territory. It suggests a neutral sentiment in the short term.
Long-term TCBP price forecast for 2025, 2030, 2035, 2040, 2045 and 2050
Based on our analysis about Tc Biopharm Holdings Plc Adr financial reports and earnings history, Tc Biopharm Holdings Plc Adr (TCBP) stock could reach $2,468.96 by 2030, $5,335.37 by 2040 and $7,500.72 by 2050. See the projected annual prices until 2050 of the Tc Biopharm Holdings Plc Adr stock below:
- Tc Biopharm Holdings Plc Adr (TCBP) is expected to reach an average price of $3,921.15 in 2035, with a high prediction of $4,096.71 and a low estimate of $3,934.55. This indicates an $200.98K% rise from the last recorded price of $1.95.
- Tc Biopharm Holdings Plc Adr (TCBP) stock is projected to chart a bullish course in 2040, with an average price target of $5,215.65, representing an $267.37K% surge from its current level. The forecast ranges from a conservative $5,222.05 to a sky-high $5,335.37.
- Our analysts predict Tc Biopharm Holdings Plc Adr (TCBP) to jump 323.19K% by 2045, soaring from $6,306.34 to an average price of $6,304.14, potentially reaching $6,528.11. While $6,306.34 is the low estimate, the potential upside is significant.
- Tc Biopharm Holdings Plc Adr (TCBP) stock is expected to climb by 2050, reaching an average of $7,227.48, a $370.54K% jump from its current level. However, a wide range of estimates exists, with high and low targets of $7,500.72 and $7,230.28, respectively, highlighting the market's uncertainty.
Tc Biopharm Holdings Plc Adr Stock (TCBP) Year by Year Forecast
Tc Biopharm Holdings Plc Adr Stock (TCBP) Price Forecast for 2025
Tc Biopharm Holdings Plc Adr Stock (TCBP) is expected to reach an average price of $578.51 in 2025, with a high prediction of $746.52 and a low estimate of $410.51. This indicates an +29,567% rise from the last recorded price of $1.95.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| March, 2025 | $744.78 | $751.52 | $746.52 | +38,094% |
| April, 2025 | $667.70 | $689.90 | $730.83 | +34,141% |
| May, 2025 | $580.79 | $613.79 | $645.72 | +29,684% |
| June, 2025 | $630.28 | $623.46 | $619.14 | +32,222% |
| July, 2025 | $612.20 | $613.19 | $613.35 | +31,295% |
| August, 2025 | $584.69 | $585.08 | $592.02 | +29,884% |
| September, 2025 | $545.38 | $546.58 | $569.71 | +27,868% |
| October, 2025 | $501.15 | $501.40 | $534.25 | +25,600% |
| November, 2025 | $457.99 | $459.59 | $486.92 | +23,387% |
| December, 2025 | $409.31 | $410.51 | $440.82 | +20,890% |
Tc Biopharm Holdings Plc Adr Stock (TCBP) Price Forecast for 2026
The predicted value for Tc Biopharm Holdings Plc Adr (TCBP) in 2026 is set at an average of $573.56. Estimates vary from a peak of $1,137.09 to a trough of $10.03, indicating an +29,313% surge from the present price of $1.95.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2026 | $372.52 | $373.00 | $398.73 | +19,004% |
| February, 2026 | $333.29 | $333.67 | $361.72 | +16,992% |
| March, 2026 | $292.98 | $293.78 | $321.52 | +14,925% |
| April, 2026 | $244.48 | $244.49 | $279.81 | +12,437% |
| May, 2026 | $208.77 | $208.83 | $235.32 | +10,606% |
| June, 2026 | $170.00 | $170.04 | $198.14 | +8,618% |
| July, 2026 | $119.94 | $120.16 | $160.01 | +6,051% |
| August, 2026 | $79.77 | $79.97 | $109.87 | +3,991% |
| September, 2026 | $29.88 | $29.97 | $69.73 | +1,432% |
| October, 2026 | $1,337.09 | $10.03 | $1,137.09 | +68,469% |
| November, 2026 | $1,267.27 | $1,137.22 | $1,012.18 | +64,888% |
| December, 2026 | $1,237.50 | $1,107.41 | $997.32 | +63,362% |
Tc Biopharm Holdings Plc Adr Stock (TCBP) Price Forecast for 2027
For 2027, Stockscan's Analyst expects the average price target for Tc Biopharm Holdings Plc Adr (TCBP) is $1,584.77, with a high forecast of $1,878.83 and a low forecast of $1,290.71. This indicates an +81,170% increase from the last price of $1.95.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2027 | $1,887.79 | $1,627.59 | $1,788.69 | +96,710% |
| February, 2027 | $1,824.97 | $1,830.87 | $1,878.83 | +93,488% |
| March, 2027 | $1,720.10 | $1,767.10 | $1,787.92 | +88,110% |
| April, 2027 | $1,690.39 | $1,694.65 | $1,669.54 | +86,587% |
| May, 2027 | $1,673.37 | $1,652.83 | $1,658.33 | +85,714% |
| June, 2027 | $1,658.13 | $1,658.16 | $1,623.61 | +84,932% |
| July, 2027 | $1,597.89 | $1,613.79 | $1,628.65 | +81,843% |
| August, 2027 | $1,592.47 | $1,595.07 | $1,603.98 | +81,565% |
| September, 2027 | $1,489.70 | $1,509.90 | $1,563.12 | +76,295% |
| October, 2027 | $1,385.89 | $1,401.89 | $1,405.44 | +70,971% |
| November, 2027 | $1,335.27 | $1,337.47 | $1,349.74 | +68,376% |
| December, 2027 | $1,287.91 | $1,290.71 | $1,313.12 | +65,946% |
Tc Biopharm Holdings Plc Adr Stock (TCBP) Price Forecast for 2028
In 2028, Tc Biopharm Holdings Plc Adr (TCBP) is projected to reach an average price of $771.85, with a high projection of $1,262.35 and a low estimate of $281.35. This indicates an +39,482% rise from the last price of $1.95.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2028 | $1,217.89 | $1,218.29 | $1,262.35 | +62,356% |
| February, 2028 | $1,142.88 | $1,144.68 | $1,193.54 | +58,509% |
| March, 2028 | $1,048.23 | $1,049.51 | $1,123.08 | +53,656% |
| April, 2028 | $971.59 | $971.89 | $1,027.17 | +49,725% |
| May, 2028 | $871.26 | $871.72 | $949.34 | +44,580% |
| June, 2028 | $791.11 | $791.63 | $849.23 | +40,470% |
| July, 2028 | $713.91 | $714.69 | $769.85 | +36,511% |
| August, 2028 | $612.12 | $613.50 | $690.34 | +31,291% |
| September, 2028 | $534.35 | $535.31 | $590.18 | +27,303% |
| October, 2028 | $459.44 | $459.86 | $513.75 | +23,461% |
| November, 2028 | $360.70 | $360.78 | $437.79 | +18,398% |
| December, 2028 | $281.23 | $281.35 | $340.86 | +14,322% |
Tc Biopharm Holdings Plc Adr Stock (TCBP) Price Forecast for 2029
The 2029 price forecast for Tc Biopharm Holdings Plc Adr Stock (TCBP) is $1,514.59 on average, with a high prediction of $3,007.70 and a low estimate of $21.48. This represents an +77,571% increase from the previous price of $1.95.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2029 | $180.86 | $181.04 | $260.94 | +9,175% |
| February, 2029 | $101.12 | $101.13 | $160.90 | +5,085% |
| March, 2029 | $51.36 | $21.48 | $81.23 | +2,534% |
| April, 2029 | $2,385.77 | $2,445.77 | $2,405.63 | +122.25K% |
| May, 2029 | $2,136.11 | $2,306.11 | $2,215.98 | +109.44K% |
| June, 2029 | $2,772.89 | $2,635.05 | $2,721.89 | +142.10K% |
| July, 2029 | $2,967.27 | $2,994.27 | $3,007.70 | +152.07K% |
| August, 2029 | $2,837.02 | $2,843.02 | $2,916.81 | +145.39K% |
| September, 2029 | $2,727.19 | $2,733.72 | $2,797.09 | +139.76K% |
| October, 2029 | $2,621.14 | $2,632.04 | $2,688.66 | +134.32K% |
| November, 2029 | $2,597.42 | $2,607.92 | $2,569.21 | +133.10K% |
| December, 2029 | $2,530.09 | $2,537.59 | $2,547.99 | +129.65K% |
Tc Biopharm Holdings Plc Adr Stock (TCBP) Price Forecast for 2030
Tc Biopharm Holdings Plc Adr Stock (TCBP) is expected to reach an average price of $1,801.58 in 2030, with a high forecast of $2,468.96 and a low forecast of $1,134.20. This signifies an +92,289% surge from the last price of $1.95.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2030 | $2,451.74 | $2,460.54 | $2,468.96 | +125.63K% |
| February, 2030 | $2,351.82 | $2,372.62 | $2,417.64 | +120.51K% |
| March, 2030 | $2,207.10 | $2,229.29 | $2,208.69 | +113.08K% |
| April, 2030 | $2,040.37 | $2,073.37 | $2,165.17 | +104.53K% |
| May, 2030 | $1,966.32 | $1,981.52 | $2,038.81 | +100.74K% |
| June, 2030 | $1,892.20 | $1,893.19 | $1,937.99 | +96,936% |
| July, 2030 | $1,753.94 | $1,756.14 | $1,852.07 | +89,846% |
| August, 2030 | $1,636.67 | $1,637.02 | $1,720.41 | +83,832% |
| September, 2030 | $1,521.75 | $1,522.00 | $1,606.49 | +77,939% |
| October, 2030 | $1,365.65 | $1,369.85 | $1,487.57 | +69,933% |
| November, 2030 | $1,250.32 | $1,251.52 | $1,336.34 | +64,019% |
| December, 2030 | $1,133.72 | $1,134.20 | $1,219.79 | +58,040% |
2.95%
0.31%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):